Flow Health CEO and founder Alex Meshkin argued excessive stimulus spending and failure to stop COVID led to the Silicon Valley Bank failure on 'The Big Money Show.'
Former Trump senior economic adviser Steve Moore blasted Biden's proposed 'tax and spend' budget, arguing it would kill the economy, stifle growth and crush investors on 'Cavuto: Coast to Coast.'
Sen. Mike Braun, R-Ind., discusses the significance of a bill that declassifies information about the origins of COVID-19 on 'The Big Money Show.'
The FDA will decide on July 6 whether to grant full approval to the new Alzheimer's treatment Leqembi, Japanese drugmaker Eisai and its U.S. partner Biogen said.
Congressional Budget Office Director Phillip Swagel discusses Biden's plan to address social security insolvency in his federal budget proposal on 'Cavuto: Coast to Coast.'
Rep. Dan Meuser, R-Pa., on 'misspeak' regarding the origins of COVID-19, holding China accountable, the U.S. sending weapons to Taiwan and the possible debt showdown in Congress.
Fox News medical contributor Dr. Marc Siegel speaks to members of the East Palestine community after new research revealed higher-than-normal levels of toxicity around the train derailment site.
Former U.S. Ambassador to NATO Kurt Volker discusses Sen. Tom Cotton's suspicions about the origins of COVID-19, another agency assessing the Chinese lab leak theory, the Ukraine-Russia war and Iran's rising aggression.
The Enchanted Salon owner Toma Rhodes says her customers 'are just afraid' to have their hair possibly washed by contaminated water from the toxic train spill.
Graviton Biopharmaceuticals Holdings CEO Sam Waksal discusses the promising Alzheimer drug that is expected to receive full approval from the FDA this summer on ‘Varney & Co.’
East Palestine resident Luke Glavan says he's not drinking any city or tap water and instead has been depending on donated water bottles.
In the Ohio toxic train derailment aftermath, The Expert Press CEO Dave Maney argues Norfolk Southern Railway should've shown up to help from the start.
Precision Neuroscience is introducing a breakthrough in medical science, which will allow those who live with limited-mobility conditions to manipulate electronics with their minds.
Precision Neuroscience co-founders Michael Mager of New York and Craig Mermel of California explain how the novel innovation works.
Stryker CEO Kevin Lobo discusses whether the expected surge in the orthopedics markets will drive sales in 2023 on 'The Claman Countdown.'
Fox News medical contributor Dr. Nicole Saphier discusses the dangers of using the diabetes drug Ozempic for weight loss on 'The Big Money Show.'
